Introduction to CEUS for Abdominal Applications: watch here
Introduction to CEUS for Echocardiography: watch here
Special thanks to ICUS Board Member Bev Gorman, the Intersocietal Accreditation Commission, and speakers Cyndi Peterson and Pam Burgess.
Ultrasound can provide a safe and reliable imaging option for Covid-19 patients, and the addition of an ultrasound enhancing agent may be essential for evaluating heart and lung function.
CLICK HERE to find protocols for protecting personnel, disinfecting equipment, safely administering ultrasound contrast or enhancing agents, and appropriately imaging these highly vulnerable patients. Additional submissions may be sent to info@icus-society.org
ICUS supports the global ultrasound community during this rapidly evolving global crisis and extends heartfelt wishes for your safety and health as we come together to defeat this deadly virus.
The ICUS Bubble Blog showcases real-life CEUS experiences from around the world, with a special focus on how CEUS impacts individual patients and their care.
By Garvit Devmohan Khatri
MBBS Fellow Abdominal Imaging, Department of Radiology, University of Washington, Seattle, WA
Mr. Y is a 48-year-old healthy man who noticed palpable tiny lumps near his armpits and immediately sought medical attention. His physician ordered a biopsy, which indicated a low-grade malignancy known as “epithelioid hemangioendothelioma’ -- often found in many parts of the body, including the liver and lungs, at the same time.
A follow up CT scan was performed to screen for other masses. It showed an indeterminate small 1 cm mass in the right lower aspect of the liver. Then a follow up MR exam was performed for further evaluation and to exclude more smaller masses that may not be well visible with CT. The MR scan did not show more masses but showed targetoid appearance of the known liver mass without showing all the imaging features of an epithelioid hemangioendothelioma. With these inconclusive findings, an ultrasound guided biopsy was needed.
